Ann Arbor, MI, March 10, 2016 – ENDRA Life Sciences, a provider of advanced ultrasound technologies, announced today it will present at the 28th Annual ROTH Capital Conference on Tuesday, March 15, 2016. The Conference will be held at the Ritz Carlton in Dana Point, California, March 13 – 16, 2016.

The Company's presentation will be delivered by Interim Chief Financial Officer David Wells. Investors interested in arranging a meeting with ENDRA management should contact Mr. Wells at (310) 800-7175

About the 28th Annual ROTH Conference

ROTH Conferences are among the largest in the nation for small-cap companies, combining company presentations, Q&A sessions and management one-on-one meetings. The 28th Annual ROTH Conference will include presentations by close to 500 growth companies across a variety of sectors, including clean-tech & solar, healthcare, technology and media.

About ENDRA

ENDRA Life Sciences is privately held, and has a mission to bring new capabilities to ultrasound. ENDRA currently markets photo-acoustic ultrasound technology, under the brand name Nexus-128™ to pre-clinical researchers studying diseases like cancer. ENDRA’s newest technology, Thermo Acoustic Enhanced Ultrasound (TAEUS™), will enable clinicians to visualize tissue composition, function and temperature at the point-of-care, in ways previously possible only on CT and MRI. For further information, visit http://www.endrainc.com

Forward-looking Statements

All statements in this announcement that are not based on historical fact are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and the provisions of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. While management has based any forward-looking statements contained herein on its current expectations, the information on which such expectations were based may change. These forward-looking statements rely on a number of assumptions concerning future events and are subject to a number of risks, uncertainties, and other factors.

ENDRA operates in a highly competitive and rapidly changing environment, thus new or unforeseen risks may arise. Accordingly, investors should not place any reliance on forward-looking statements as a prediction of actual results. The Company disclaims any intention to, and undertakes no obligation to, update or revise any forward-looking statements.

Contact

Scott Arnold / CorProminence LLC

(310) 497-8817
scotta@corprominence.com